The correlation between STC2 expression and the expression of epithelial markers such as E-cadherin (CDH1) or the mesenchymal marker such as Vimentin (VIM) were evaluated in 178 pancreatic cancer cases from the TCGA database, and the data revealed that the mRNA level of STC2 was negatively correlated with CDH1, and highly positively correlated with VIM. Here, VIM is linked to pancreatic neoplasm.